Annette Marcantonio
Corporate Officer/Principal en JASPER THERAPEUTICS, INC. .
Perfil
Annette Marcantonio is currently the Vice President of Clinical Operations at Jasper Therapeutics, Inc. Prior to this, she held the same position at Aimmune Therapeutics, Inc. from 2016 to 2020.
She received her undergraduate degree from Loyola Marymount University.
Cargos activos de Annette Marcantonio
| Empresas | Cargo | Inicio |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2023 |
Antiguos cargos conocidos de Annette Marcantonio.
| Empresas | Cargo | Fin |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2020 |
Formación de Annette Marcantonio.
| Loyola Marymount University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Empresas privadas | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Annette Marcantonio
